Leading Cord Blood Bank Offers Greater Chance of Future Treatment Success
The CD34+ stem cells every cord blood bank preserves have treated over 80 potentially life-threatening diseases and conditions afflicting more than 10,000 patients to date. These stem cells have vast regenerative properties, and their availability during treatment is directly tied to the treatment’s effectiveness. Research shows that the availability of more CD34+ stem cells can improve transplant success and patient survival.
It is for this reason that a number of cord blood banks aim to collect large amounts of stem cells in hopes of granting expecting parents greater peace of mind. But before investing in a bank’s services, parents should be certain that the bank’s Total Nucleated Cell (TNC) count is not artificially inflated by the inclusion of nucleated red blood cells. The inclusion of these cells in a bank’s TNC may lead parents to mistakenly believe that more lifesaving stem cells will be available for their family’s potential future use. Even worse, stem cell units with high concentrations of nucleated red blood cells may even lead to complications when used to treat life-threatening diseases and conditions.
LifebankUSA® has cemented its status as a leading cord blood bank by offering stem cell units that are 99% red blood cell depleted, and giving parents the option of collecting more CD34+ stem cells through its unique Placenta-Cord banking service. This service can double, on average, the number of lifesaving stem cells collected from cord blood banking alone, thereby offering families a greater chance of future treatment success.
admin @ May 26, 2009